Godrej Consumer Products Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/7bhocsnrxv412ifbyt29fkpk.pdf

Key Takeaways


India Business: What Went Wrong

Sitapati: "Q3 FY '25 has been a tough quarter for GCPL. In particular, our India business has had a poor performance, which has been somewhat compensated by our International business."

Palm Oil & Margin Math

Sitapati: "I think there is requirement for another round of pricing in Soaps in particular... we are not done with the pricing because at the end of the day, we have to get back to our nominative margins."

RNF: The Household Insecticides Bet

Sitapati: "We do a dipstick. We just did one to check the awareness of the product, and it is very high. The awareness of the product is high. November market shares were good, December was even better. So I feel we'll just have to give this a few more months to call this."

International: The Offset

Sitapati: "We were quite brutal about getting to this mid-high teens kind of margins and even if it came at the cost of business, we said, it doesn't matter. Having now got to this kind of margin structure, I guess we've got to start growing now."

Portfolio Moves & Distribution


Guidance & Commitments

CommitmentSpecificsTimeline
Volume recoverySequential improvement from Q3; Q4 not back to H1 levelsQ4 FY25; Q1 FY26 for H1-level volumes
India margin normalizationReturn to 24-26% EBITDA range (approximately 150 bps above current)Next 6-8 months; lower end of band for full-year FY26
Soap marginsNormalize from current compressed levelsNext 2-3 quarters
GAUM organic revenue growthTurn positiveQ4 FY25
Africa marginsAdditional 100-200 bps expansion from approximately 15%Undated; growth focus now
RNF full assessmentClear read on how well RNF is workingBy March (end of Q1 next season)
Old-product manufacturing phase-outStop manufacturing old formulation for modern trade and e-commerceBy March
Raymond marginsReach 20%-odd first; 25% aspiration is "fullness of time"Undated

Key Metrics

MetricQ3 FY25
Consolidated organic revenue growth6% in rupee terms
Consolidated organic volume growthFlat
Consolidated reported EBITDA growth-10%
India business revenue growth4%
India business volume growthFlat
India business EBITDA growth-21%
India business EBITDA margin~22.5%, normal range expected at 24-26%
Soaps EBITDA marginJust short of 20%
Advertising spend~10% of sales, held steady
Indonesia volume growth6%
Indonesia revenue growth9%
Indonesia EBITDA growth12%
Africa (GAUM) revenue growth-8%
Africa (GAUM) EBITDA growth9%
GAUM operating margin~15%, past 4 quarters; scope for another 100-200 bps increase
Latin America volume growthGreater than 25%
Latin America EBITDA marginDouble digits
Household Insecticides RNF offtakes in Liquid Vaporizers40-50% of end-consumer offtakes
Incense Sticks overall market shareHigh single digits
Incense Sticks handler shareClose to 50%
Palm oil price decline from peak~20%, from MYR5,200 to MYR4,200
PFAD price decline from peak7-8%
Raymond business EBITDA marginMid-teens, up from mid-single digits at acquisition
India portfolio structure~1/3 Soaps, 1/3 Household Insecticides, 1/3 all others
Q4 India margin outlookMore of the same as Q3
Target India margin normalization timelineNext 6-8 months
FY'26 India margin assumptionLower end of 24-26% (per an analyst's math)